Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Dare Bioscience, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q2 2024
- Shares held
- 655.4K
- +70.9K (+12.1%) vs. Q2 2024Converted for a 1-for-12 split
- Total value
- $2.08M
- −$309.5K (−13.0%) vs. Q2 2024
- New holders
- 6
- 11 more added
- Sold out
- 11
- 2 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 287,725 | $932.2K | 0.00% | +7,874+2.8% | AddedConverted for a 1-for-12 split |
| AMH Equity Ltd | 100,000 | $324.0K | 0.43% | +23,032+29.9% | AddedConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 89,060 | $288.6K | 0.00% | +5,180+6.2% | AddedConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 64,395 | $208.6K | 0.00% | −497−0.8% | ReducedConverted for a 1-for-12 split |
| State Street Corp | 23,515 | $76.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Commonwealth Equity Services, LLC | 17,486 | $57.0K | 0.00% | +13,659+356.9% | AddedConverted for a 1-for-12 split |
| BlackRock, Inc. | 16,971 | $55.0K | 0.00% | +16,971 | New |
| Northern Trust Corp | 15,459 | $50.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Founders Financial Securities LLC | 11,586 | $37.5K | 0.00% | +11,586 | New |
| Price T Rowe Associates Inc | 10,491 | $34.0K | 0.00% | +10,491 | New |
| Advisory Services Network, LLC | 15,000 | $5.04K | 0.00% | +13,750+1,100.0% | AddedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 1,507 | $4.88K | 0.00% | +232+18.2% | AddedConverted for a 1-for-12 split |
| Insight Financial Services | 950 | $3.08K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| UBS Group AG | 885 | $2.87K | 0.00% | −7,366−89.3% | ReducedConverted for a 1-for-12 split |
| Mather Group, LLC. | 84 | $272 | 0.00% | +1+0.8% | AddedConverted for a 1-for-12 split |
| Bank of America Corp | 83 | $269 | 0.00% | +1+1.5% | AddedConverted for a 1-for-12 split |
| Bryn Mawr Trust Co | 71 | $230 | 0.00% | +71 | New |
| EverSource Wealth Advisors, LLC | 42 | $136 | 0.00% | +42 | New |
| JPMorgan Chase & Co | 21 | $68 | 0.00% | +0+1.2% | AddedConverted for a 1-for-12 split |
| Caldwell Sutter Capital, Inc. | 17 | $55 | 0.00% | +0+2.0% | AddedConverted for a 1-for-12 split |
| Planning Capital Management Corp | 9 | $30 | 0.00% | +9 | New |
| Cornerstone Planning Group LLC | 2 | $8 | 0.00% | +2+1,100.0% | AddedConverted for a 1-for-12 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −8,575−100.0% | Sold outConverted for a 1-for-12 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,913−100.0% | Sold outConverted for a 1-for-12 split |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −2,573−100.0% | Sold outConverted for a 1-for-12 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −2,544−100.0% | Sold outConverted for a 1-for-12 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −2,162−100.0% | Sold outConverted for a 1-for-12 split |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −1,667−100.0% | Sold outConverted for a 1-for-12 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,667−100.0% | Sold outConverted for a 1-for-12 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −929−100.0% | Sold outConverted for a 1-for-12 split |
| Cerity Partners LLC | 0 | $0 | 0.00% | −833−100.0% | Sold outConverted for a 1-for-12 split |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold outConverted for a 1-for-12 split |
| FMR LLC | 0 | $0 | 0.00% | −42−100.0% | Sold outConverted for a 1-for-12 split |
| BlackRock Inc. | – | – | – | – | Not filed |